Osteoporosis is a metabolic bone disorder commonly occurred in aging populations, particularly postmenopausal women and patients who undergo long-term steroid or anti-estrogen therapies. Given the rapid growth of the aging population, the prevalence of bone loss, and the huge medical and healthcare cost involved, demand for alternative approaches for the promotion of bone health is pressing. With the advent of global interest in complementary and alternative medicine and natural products, Chinese medicine serves as a viable source that offers benefits to improve and maintain bone health. This review summarizes the scientific information on the Chinese medicinal herb Ligustrum lucidum and its chemical components as potential therapy for osteoporosis.
Anon. (2015) International Osteoporosis Foundation: Facts and statistics about osteoporosis and its impact. International Osteoporosis Foundation.
2.
Anon. (2015) National Osteoporosis Foundation Prevalence Report. National Osteoporosis Foundation.
3.
TellaSH, GallagherJC. (2014) Prevention and treatment of postmenopausal osteoporosis. Journal of Steroid Biochemistry and Molecular Biology, 142, 155–170.
4.
SandhuSK, HampsonG. (2011) The pathogenesis, diagnosis, investigation and management of osteoporosis. Journal of Clinical Pathology, 64, 1042–1050.
5.
SweetMG, SweetJM, JeremiahMP, SalazkaSS. (2009) Diagnosis and treatment of osteoporosis. American Family Physician, 79, 193–200.
6.
RachnerTD, KhoslaS, HofbauerLC. (2011) Osteoporosis: now and the future. Lancet, 377, 1276–1287.
7.
HollickRJ, ReidDM. (2011) Role of bisphosphonates in the management of postmenopausal osteoporosis: an update on recent safety anxieties. Menopause International, 17, 66–72.
8.
Park-WyllieLY, MamdaniMM, JuurlinkDN, HawkerGA, GunrajN, AustinPC, WhelanDB, WeilerPJ, LaupacisA. (2011) Bisphosphonate use and the risk of subtrochanteric or femoral shaft fracture in older women. The Journal of the American Medical Association, 305, 783–789.
9.
LewieckiEM. (2011) Safety of long-term bisphosphonate therapy of the management of osteoporosis. Drugs, 71, 791–814.
10.
WattsNB, DiabDL. (2010) Long-term use of bisphosphonates in osteoporosis. Journal of Clinical Endocrinology and Metabolism, 95, 1555–1565.
11.
KosM. (2011) Bisphosphonates promote jaw osteonecrosis through facilitating bacterial colonization. Medical Hypotheses, 77, 214–215.
12.
Knopp-SihotaJA, CummingsGG, HomikJ, VoaklanderD. (2013) The association between serious upper gastrointestinal bleeding and incident bisphosphonate use: a population-based nested cohort study. BMC Geriatrics, 13, 36.
13.
HonigS. (2010) Osteoporosis, new treatment and updates. Bulletin of the New York University Hospital for Joint Diseases, 68, 166–170.
14.
SilvaBC, BilezikianJP. (2011) New approaches to the treatment of osteoporosis. Annual Review of Medicine, 62, 307–322.
15.
BowringCE, FrancisRM. (2011) National Osteoporosis Society's position statement on hormone replacement therapy in the prevention and treatment of osteoporosis. Menopause International, 17, 63–65.
16.
SpanglerM, PhillipsBB, RossMB, MooresKG. (2011) Calcium supplementation in postmenopausal women to reduce the risk of osteoporotic fractures. American Journal of Health-System Pharmcy, 68, 309–318.
17.
Quesada-GomezJM, Blanch-RubioJ, Diaz-CurielM, Diez-PerezA. (2011) Calcium citrate and vitamin D in the treatment of osteoporosis. Clinical Drug Investigation, 31, 285–298.
18.
ChongCA, Diaz-GranadosN, HawkerGA, JamalS, JosseRG, CheungAM. (2007) Complementary and alternative medicine use by osteoporosis clinic patients. Osteoporosis International, 18, 1547–1556.
19.
MakJCS, FauxS. (2010) Complementary and alternative medicine use by osteoporotic patients in Australia (CAMEO-A): a prospective study. Journal of Alternative and Complementary Medicine, 16, 579–584.
20.
NewtonKM, GradyD. (2011) Soy isoflavones for prevention of menopausal bone loss and vasomotor symptoms. Archives in Internal Medicine, 171, 1369–1370.
21.
LevisS, Strickman-SteinN, Ganjei-AzarP, XuP, DoergeDR, KrischerJ. (2011) Soy isoflavones in the prevention of menopausal bone loss and menopausal symptoms. A randomized, double-blind trial. Archives in Internal Medicine, 171, 1363–1369.
22.
TakuK, MelbyMK, NishiN, OmoriT, KurzerMS. (2011) Soy isoflavones for osteoporosis: An evidence-based approach. Maturitas, 70, 333–338.
23.
Castelo-BrancoC, Cancelo-HidalgoMJ. (2011) Isoflavones: effects on bone health. Climacteric, 14, 204–211.
24.
LethabyLE, MarjoribanksJ, KronenbergF, RobertsH, EdenJ. (2013) Phytoestrogens for menopausal vasomotor symptoms. Cochrane Database of Systematic Reviews, (12):CD001395.
25.
DepypereHT, ComhaireFH. (2014) Herbal preparation for the menopause: Beyond isoflavones and black cohosh. Maturitas, 77, 191–194.
26.
Anon. (2010) Ligustri Lucidi Fructus. In Chinese-Pharmacopoeia, 2010 Chinese Edition, Part 1, Chinese Medical and Pharmaceutical Press, Beijing (China), p. 43.
27.
KongYC. (2010) Huangdi Neijing: a synopsis with commentaries, The Chinese University Press, Hong Kong, p. 131.
28.
ZhangY, LaiWP, LeungPC, WuCF, YaoXS, WongMS. (2006) Effects of Fructus Ligustri Lucidi extract on bone turnover and calcium balance in ovariectomized rats. Biological Pharmaceutical Bulletin, 29, 291–296.
29.
ZhangY, HuangW, ChenB, LeungPC, WuCF, YaoXS. (2006) Effect of Fructus Ligustri Lucidi on calcium metabolism and vitamin D-dependent gene expressions in ovariectomized rats. Zhongcaoyao, 37, 558–561.
30.
ZhangY, LaiWP, LeungPC, CheCT, WongMS. (2008) Improvement of Ca balance by Fructus Ligustri Lucidi extract in aged female rats. Osteoporosis International, 19, 235–242.
31.
ZhangY, LeungPC, CheCT, ChowHK, WuCF, WongMS. (2008) Improvement of bone properties and enhancement of mineralization by ethanol extract of Fructus Ligustri Lucidi. British Journal of Nutrition, 99, 494–502.
32.
KoCH, SiuWS, LauCP, LauCBS, FungKP, LeungPC. (2010) Osteoprotecticve effects of Fructus Ligustri Lucidi aqueous extract in aged ovariectomized rats. Chinese Medicine, 5, 39.
33.
KangX, LiZ, ZhangWH, ZhouQ, LiuRH, WangXJ. (2013) Study on the effect of combination of Epimedii Folium and Ligustri Lucidi Fructus on osteoporosis rats induced by retinoic acid. Zhongguo Zhongyao Zazhi, 38, 4124–4128.
ZhangY, DongXL, LeungPC, CheCT, WongMS. (2008) Fructus Ligustri Lucidi extract improves calcium balance and modulates the calciotropic hormone level and vitamin D-dependent gene expression in aged ovariectomized rats. Menopause, 15, 558–565.
39.
DongXL, ZhaoM, WongKK, CheCT, WongMS. (2012) Improvement of calcium balance by Fructus Ligustri Lucidi extract in mature female rats was associated with the induction of serum parathyroid hormone levels. British Journal of Nutrition, 108, 92–101.
40.
LyuY, FengX, ZhaoP, WuZ, XuH, FangY, HouY, DenneyL, XuY, FengH. (2014) Fructus Ligustri Lucidi ethanol extract increases bone mineral density and improves bone properties in growing female rats. Journal of Bone Mineral Metabolism, 32, 616–626.
41.
FengX, YingL, WuZ, FangY, XuH, ZhaoP, XuY, FengH. (2014) Fructus ligustri lucidi ethanol extract improves bone mineral density and properties through modulating calcium absorption-related gene expression in kidney and duodenum of growing rats. Calcified Tissue International, 94, 433–441.
42.
ZhangY, DiaoTY, WangL, CheCT, WongMS. (2014) Protective effects of water fraction of Fructus Ligustri Lucidi extract against hypercalciuria and trabecular bone deterioration in experimentally type 1 diabetic mice. Journal of Ethnopharmacology, 158 (Pt A), 239–245.
43.
WuYB, LinXH, WuJG, YiJ, ZhengYZ, WuJZ. (2011) Volatile components of fruits of Ligustrum lucidum Ait. stimulate proliferation and differentiation of rat calvarial osteoblasts. African Journal of Biotechnology, 10, 8662–8668.
44.
HuangXP, WangWC. (2011) Chemical constituents of Ligustrum lucidum fruits: research advances. Guoji Yaoxue Yanjiu Zazhi, 38, 47–51.
45.
ZhaoL, FengY. (2012) Advances in research on triterpenoids and iridoids of Ligustri Lucidi Fructus. Guangdong Yaoxeuyuan Xuebao, 28, 107–110.
46.
ZhangJ, WangX, DengZ, LiX. (2013) Advances in research on chemical components and pharmacological effects of Chinese medicine Ligustrum lucidum fruit. Xiandai Zhongxiyi Jiehe Zazhi, 22, 4100–4101.
47.
GaoL, LiCY, WangZ, LiuX, YouY, WeiH, GuoT. (2015) Ligustri Lucidi Fructus as a traditional Chinese medicine: a review of its phytochemistry and pharmacology. Natural Products Research, 29, 493–510.
48.
LiJX, HareyamaT, TezukaY, ZhangY, MiyaharaT, KadotaS. (2005) Five new oleanolic acid glycosides from Achyranthes bidentata with inhibitory activity on osteoclast formation. Planta Medica, 71, 673–679.
49.
ZhangY, LiJX, ZhaoJ, WangSZ, PanY, TanakaK, KadotaS. (2005) Synthesis and activity of oleanolic acid derivatives, a novel class of inhibitors of osteoclast formation. Bioorganic and Medicinal Chemistry Letters, 15, 1629–1632.
50.
LiJF, ZhaoYJ, CaiMM, LiXF, LiJX. (2009) Synthesis and evaluation of a novel series of heterocyclic oleanolic acid derivatives with anti-osteoclast formation activity. European Journal of Medicinal Chemistry, 44, 2796–2806.
51.
LiJF, ChenSJ, ZhaoY, LiJX. (2009) Glycoside modification of oleanolic acid derivatives as a novel class of anti-osteoclast formation agents. Carbohydrate Research, 344, 599–605.
52.
KimJY, CheonYH, OhHM, RhoMC, ErkhembaatarM, KimMS, LeeCH, KimJJ, ChoiMK, YoonKH, LeeMS, OhJ. (2014) Oleanolic acid acetate inhibits osteoclast differentiation by downregulating PLCgamma2-Ca(2+)-NFATc1 signaling and suppresses bone loss in mice. Bone, 60, 104–111.
53.
BianQ, HuangJH, YangZ, NingY, ZhaoYJ, WangYJ, ShenZY. (2011) Effects of active ingredients in three kidney-tonifying Chinese herbal drugs on gene expression profile of bone marrow stromal cells from a rat model of corticosterone-induced osteoporosis. Zhongxiyi Jiehe Xuebao, 9, 179–185.
54.
BianQ, LiuSF, HuangJH, YangZ, TangDZ, ZhouQ, NingY, ZhaoYJ, LuS, ShenZY. (2012) Oleanolic acid exerts an osteoprotective effect in ovariectomy-induced osteoporotic rats and stimulates the osteoblastic differentiation of bone mesenchymal stem cells in vitro. Menopause, 19, 225–233.
55.
LeeSU, ParkSJ, KwakHB, OhJ, MinYK, KimSH. (2008) Anabolic activity of ursolic acid in bone: stimulating osteoblast differentiation in vitro and inducing new bone formation in vivo. Pharmacological Research, 58, 290–296.
56.
TanH, FurutaS, NagataT, OhnukiK, AkasakaT, ShirouchiB, SatoM, KondoR, ShimizuK. (2014) Inhibitory effects of the leaves of loquat (Eriobotrya japonica) on bone mineral density loss in ovariectomized mice and osteoclast differentiation. Journal of Agricultural and Food Chemistry, 62, 836–841.
57.
TanH, AshourA, Katakura Y andShimizu K. (2015) A structure-activity relationship study on antiosteoclastogenesis effect of triterpenoids from the leaves of loquat (Eriobotrya japonica). Phytomedicine, 22, 498–503.
58.
JiangC, XiaoF, GuX, ZhaiZ, LiuX, WangW, TangT, WangY, ZhuZ, DaiK, QinA, WangJ. (2015) Inhibitory effects of ursolic acid on osteoclastogenesis and titanium particle-induced osteolysis are mediated primarily via suppression of NF-kappaK signaling. Biochimie, 111, 107–118.
59.
HuangY, WuY, WuJ, YiJ, ZhangQ, ChenT, WuJ. (2014) Chemical constituents from Ligustrum lucidum differentially promote bone formation and prevent oxidative damage in osteoblastic UMR-106 cells. Latin American Journal of Pharmacy, 33, 258–265.
60.
HuangXJ, YinZQ, YeWC, ShenWB. (2010) Chemical constituents from fruits of Ligustrum lucidum. Zhongguo Zhongyao Zazhi, 35, 861–864.
61.
ChenQ, YangL, ZhangG, WangF. (2013) Bioactivity-guided isolation of antiosteoporotic compounds from Ligustrum lucidum. Phytotherapy Research, 27, 973–979.
62.
XuXH, YangNY, QianSH, XieN, DuanJA. (2008) Dammarane triterpenes from Ligustrum lucidum. Journal of Asian Natural Product Research, 10, 33–37.
63.
FengJ, FengZ, WangJ, CuiY. (2011) Triterpenoids from the fruits of Ligustrum lucidum. Zhongyaocai, 34, 1540–1544.
64.
YangNY, XuXH, RenDC, DuanJA, XieN, TianLJ, QianSH. (2010) Secoirirdoid constituents from the fruits of Ligustrum lucidum. Helvetica Chimica Acta, 93, 65–71.
65.
HuangXJ, WangY, YinZQ, YeWC. (2010) Two new dimeric secoiridoid glycosides from the fruits of Ligustrum lucidum. Journal of Asian Natural Product Research, 12, 685–690.
66.
FuG, IpFCF, PangH, IpNY. (2010) New secoiridoids from Ligustrum lucidum induce ERK and CREB phosphorylation in cultured cortical neurons. Planta Medica, 76, 998–1003.
67.
AokiS, HondaY, KikuchiT, MiuraT, SugawaraR, YaoitaY, KikuchiM, MachidaK. (2012) Six new secoiridoids from the dried fruits of Ligustrum lucidum. Chemical and Pharmaceutical Bulletin, 60, 251–256.
68.
HuangXJ, WangL, ShaoM, HuSZ, JiangRW, YaoXS, LiYL, YinZQ, WangY, YeWC. (2013) Oleonin, the first secoiridoid with alpha-configuration from Ligustrum lucidum. RSC Advances, 3, 16300–16303.
69.
BarbaroB, ToiettaG, MaggioR, ArcielloM, TarocchiM, GalliA, BalsanoC. (2014) Effects of the olive-derived polyphenol oleuropein on human health. International Journal of Molecular Sciences, 15, 18508–18524.
70.
SacchiRP A., SavareseM, VitaglioneP, FoglianoV. (2014) Extra virgin olive oil: from composition to “molecular gastronomy”. Cancer Treatment and Research, 159, 325–338.
71.
MelliouE, ZweigenbaumJA, MitchellAE. (2015) Ultrahigh-pressure liquid chromatography triple-quadrupole tandem mass spectrometry quantitation of polyphenols and secoiridoids in California-style black ripe olives and dry salt-cured olives. Journal of Agricultural and Food Chemistry, 63, 2400–2405.
72.
SalehNK, SalehHA. (2011) Olive oil efffectively mitigates overiectomzy-induced osteoporosis in rats. BMC Complementary and Alternative Medicine, 11, 10.
73.
PanossianA, WikmanG, SarrisJ. (2010) Rosenroot (Rhodiola rosea): traditional use, chemical composition, pharmacology and clinical efficacy. Phytomedicine, 17, 481–493.
74.
ChoeKI, KwonJH, ParkKH, OhMH, KimMH, KimHH, ChoSH, ChungEK, HaSY, LeeMW. (2012) The antioxidant and antiinflammatory effects of phenolic compounds isolated from the root of Rhodiola sachalinensis A. Bor. Molecules, 17, 11484–11494.
75.
ZhangSC, WangSQ, ZhaoS. (2009) The effect of salidroside on leptin expression of diabetic rats with osteoporosis. Chinese Journal of Pathophysiology, 25, 787–788.
76.
HeJ, HuXP, ZengY, LiY, WuHQ, QiuRZ, MaWJ, LiT, LiCY, HeZD. (2011) Advanced research on acteoside for chemistry and bioactivities. Journal of Asian Natural Product Research, 13, 449–464.
77.
AlipievaK, KorkinaL, OrthanIE, GeorgievMI. (2014) Verbascoside: a review of its occurrence, (bio)synthesis and pharmacological significance. Biotechnology Advances, 32, 1065–1076.
